Briefing
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
IMWG defined MRD-negativity response categories (with or without imaging-based absence of extramedullary disease) to allow uniform reporting, using bone-marrow flow or sequencing plus sensitive imaging, on top of conventional CR.
- Design: consensus
- Assay: Flow cytometry or sequencing MRD, with or without imaging